The Protocol has clearly significantly shaped the development of most national biotechnology regulatory frameworks, with impacts on a range of issues including environmental risk assessment (ERA), socio-economic considerations, and liability and redress, particularly in developing countries (McLean et al., 2012 ; Adenle et al., 2018 ).
← all excerpts
When Policy Meets Practice: The Dilemma for Guidance on Risk Assessment Under the Cartagena Protocol on Biosafety.
1
—
—